BIOA

BioAge Labs Inc.

• TipRanks·08/07 13:39

  BioAge Labs price target lowered to $20 from $23 at Morgan Stanley

• TipRanks·08/06 23:40

  Analysts’ Opinions Are Mixed on These NA Stocks: BioAge Labs, Inc. (BIOA) and Fiserv (FISV)

• TipRanks·08/06 13:07

  Oppenheimer Sticks to Its Buy Rating for BioAge Labs, Inc. (BIOA)

• TipRanks·08/06 12:25

  BioAge Labs: Upstream NLRP3 Strategy and Strong Cash Runway Underpin Unchanged $35 Price Target and Buy Rating

• TipRanks·08/06 11:11

  Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL)

• TipRanks·08/06 01:45

  Andy Hsieh Reiterates Hold on BioAge as Strong Cash Runway Offsets Execution and Clinical Surrogate Uncertainties

• TipRanks·08/05 23:00

  BioAge Labs reports Q2 EPS (58c), consensus (62c)

• Seeking Alpha·08/05 22:02

  BioAge Labs GAAP EPS of -$0.58 beats by $0.03, revenue of $2.45M beats by $0.95M

• TipRanks·08/05 07:05

  BioAge Labs, Inc. (BIOA) Gets a Buy from Piper Sandler

• TipRanks·08/03 13:20

  Analysts Offer Insights on NA Companies: Central Bancompany (CBC) and BioAge Labs, Inc. (BIOA)

• TipRanks·08/01 09:00

  Analysts Have Conflicting Sentiments on These NA Companies: BioAge Labs, Inc. (BIOA) and adidas AG (GB:0OLD)

• TipRanks·07/31 18:55

  Roth MKM Reaffirms Their Buy Rating on BioAge Labs, Inc. (BIOA)

• TipRanks·07/31 18:50

  Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback

• TipRanks·07/31 18:40

  BioAge Labs price target lowered to $25 from $36 at Roth Capital

• TipRanks·07/31 18:36

  BioAge Therapeutics: Buy Rating Maintained Despite Cut in Price Target to $21 on Refined ASCVD and Ocular Program Assumptions